Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation

Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems

(2010) C. CAMMÀ et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization

(2010) J.-L. Raoul et al.   CANCER TREATMENT REVIEWS

The intermediate hepatocellular carcinoma stage: Should treatment be expanded?

(2010) Fabio Piscaglia et al.   DIGESTIVE AND LIVER DISEASE

Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma

(2010) Riccardo Lencioni et al.   SEMINARS IN LIVER DISEASE

Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinoma

(2009) E. G. GIANNINI et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Transcatheter arterial chemoembolisation for hepatocellular carcinoma in cirrhosis: Survival rate and prognostic factors

(2009) Mirko Olivo et al.   DIGESTIVE AND LIVER DISEASE

A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma

(2009) Giuseppe Cabibbo et al.   HEPATOLOGY

Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies

(2009) Puneeta Tandon et al.   LIVER INTERNATIONAL

Prognostic scores for hepatocellular carcinoma: none is the winner

(2009) Calogero Cammà et al.   LIVER INTERNATIONAL

Molecular targeted therapies in hepatocellular carcinoma

(2008) Josep M. Llovet et al.   HEPATOLOGY

Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   JNCI-Journal of the National Cancer Institute